M3-Brigade Acquisition V Corp. Class A Ordinary shares (NASDAQ:MBAV) — Market Cap & Net Worth
Market Cap & Net Worth: M3-Brigade Acquisition V Corp. Class A Ordinary shares (MBAV)
M3-Brigade Acquisition V Corp. Class A Ordinary shares (NASDAQ:MBAV) has a market capitalization of $310.50 Million ($310.50 Million) as of August 12, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #14712 globally and #3444 in its home market, demonstrating a -0.69% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying M3-Brigade Acquisition V Corp. Class A Ordinary shares's stock price $10.80 by its total outstanding shares 28750000 (28.75 Million). See MBAV equity to assets ratio to understand what proportion of total assets are financed by equity.
M3-Brigade Acquisition V Corp. Class A Ordinary shares Market Cap History: 2024 to 2026
M3-Brigade Acquisition V Corp. Class A Ordinary shares's market capitalization history from 2024 to 2026. Data shows growth from $289.23 Million to $310.50 Million (4.32% CAGR). Also see total assets of M3-Brigade Acquisition V Corp. Class A O for a full breakdown of the balance sheet.
Index Memberships
M3-Brigade Acquisition V Corp. Class A Ordinary shares is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$40.83 Trillion | 0.00% | #1431 of 3165 |
Weight: M3-Brigade Acquisition V Corp. Class A Ordinary shares's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
M3-Brigade Acquisition V Corp. Class A Ordinary shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how M3-Brigade Acquisition V Corp. Class A Ordinary shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of M3-Brigade Acquisition V Corp. Class A O for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MBAV by Market Capitalization
Companies near M3-Brigade Acquisition V Corp. Class A Ordinary shares in the global market cap rankings as of August 12, 2026. Also see M3-Brigade Acquisition V Corp. Class A O (MBAV) cash flow conversion for how efficiently the company converts equity into cash flow.
Key companies related to M3-Brigade Acquisition V Corp. Class A Ordinary shares by market ranking:
- Twenty One Capital, Inc. (NYSE:XXI): Ranked #7018 globally with a market cap of $1.59 Billion USD.
- Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ:DMII): Ranked #11031 globally with a market cap of $643.37 Million USD.
- Ares Acquisition Corporation II (NYSE:AACT): Ranked #11465 globally with a market cap of $587.05 Million USD.
- Churchill Capital Corp XI (NASDAQ:CCXI): Ranked #11630 globally with a market cap of $568.14 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #7018 | Twenty One Capital, Inc. | NYSE:XXI | $1.59 Billion | $4.58 |
| #11031 | Drugs Made In America Acquisition II Corp. Ordinary Shares | NASDAQ:DMII | $643.37 Million | $10.12 |
| #11465 | Ares Acquisition Corporation II | NYSE:AACT | $587.05 Million | $9.49 |
| #11630 | Churchill Capital Corp XI | NASDAQ:CCXI | $568.14 Million | $16.10 |
M3-Brigade Acquisition V Corp. Class A Ordinary shares Historical Marketcap From 2024 to 2026
Between 2024 and today, M3-Brigade Acquisition V Corp. Class A Ordinary shares's market cap moved from $289.23 Million to $ 310.50 Million, with a yearly change of 4.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $310.50 Million | +1.60% |
| 2025 | $305.61 Million | +5.67% |
| 2024 | $289.23 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 11th, 2026 the market cap of M3-Brigade Acquisition V Corp. Class A Ordinary shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $310.50 Million USD |
| MoneyControl | $310.50 Million USD |
| MarketWatch | $310.50 Million USD |
| marketcap.company | $310.50 Million USD |
| Reuters | $310.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About M3-Brigade Acquisition V Corp. Class A Ordinary shares
M3-Brigade Acquisition V Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. M3-Brigade Acquisition V Corp. was incorporated in 2024 and is based in New York, New York.